Liver Biopsy Cost in Hyderabad, India – 2026 Guide

A liver biopsy is not required for everyone with liver disease. It is usually recommended when blood tests, imaging studies, or other investigations cannot provide a definite diagnosis or when doctors need to assess the severity of liver damage to guide treatment decisions.

Common Conditions Indicating Need for a Liver Biopsy

• Unexplained Abnormal Liver Function Tests (LFTs):  When liver enzyme levels remain abnormal without a clear cause, a liver biopsy may help identify the underlying liver disease and determine the extent of liver damage.
• Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH):  A liver biopsy helps determine whether simple fatty liver has progressed to inflammation (NASH), fibrosis, or cirrhosis, allowing doctors to plan appropriate treatment.
• Chronic hepatitis B and hepatitis C: In patients with chronic viral hepatitis, a liver biopsy may be recommended to assess the degree of liver inflammation and scarring (fibrosis), which helps guide treatment decisions and predict long-term outcomes.
• Liver fibrosis and cirrhosis: When liver scarring is suspected, a biopsy can accurately determine the stage of fibrosis or cirrhosis and help estimate the severity of liver disease.
• Autoimmune liver diseases: Conditions such as autoimmune hepatitis, primary biliary cholangitis (PBC), or primary sclerosing cholangitis (PSC) may require a liver biopsy to confirm the diagnosis and assess disease severity.
• Alcohol-related liver disease: In selected patients, a liver biopsy may help evaluate the extent of liver injury, inflammation, and fibrosis caused by long-term alcohol consumption.
• Liver tumours or abnormal liver lesions: When imaging studies cannot clearly identify whether a liver mass is benign or cancerous, a liver biopsy may be performed to obtain tissue for microscopic examination and establish an accurate diagnosis.
• Inherited or metabolic liver disorders: Liver biopsy is recommended to assess liver damage and support diagnosis of the conditions.
• Liver transplant evaluation: In patients who have undergone liver transplantation, a liver biopsy may be performed to detect rejection, recurrent liver disease, infection, or other complications affecting the transplanted liver.
• Drug-Induced Liver Injury (DILI): When medications or herbal supplements are suspected of causing liver damage and the diagnosis remains uncertain, a liver biopsy may help identify the pattern and severity of injury, guiding further treatment and medication management.

While a liver biopsy is a safe and commonly performed diagnostic procedure, it is not suitable for everyone. Certain medical conditions or health risks may increase the likelihood of complications or require an alternative biopsy approach.

• Uncontrolled bleeding disorders:  Patients with severe clotting abnormalities or low platelet counts have a higher risk of bleeding after the procedure and may require correction before a liver biopsy or an alternative approach, such as a transjugular liver biopsy.
• Active infection at the biopsy site: Skin or soft tissue infections over the area where the biopsy needle would be inserted may increase the risk of spreading infection and usually need treatment before the procedure.
• Large amounts of fluid in the abdomen (Massive Ascites):  Significant ascites can make a standard percutaneous liver biopsy difficult or unsafe. In such cases, a transjugular liver biopsy may be recommended instead.
• Inability to cooperate during the procedure: Patients who cannot remain still, follow instructions, or have severe anxiety or altered consciousness may not be suitable for a percutaneous liver biopsy without additional support or sedation.
• Severe cardiopulmonary instability: Patients with unstable heart or lung conditions may require medical stabilisation before undergoing a liver biopsy to reduce the risk of complications.

A detailed assessment by a qualified gastroenterologist, hepatologist, or interventional radiologist is essential to determine whether a liver biopsy is appropriate. A comprehensive pre-procedure evaluation, imaging studies, and an overall health assessment help ensure that the procedure is performed safely and that the most accurate diagnostic information is obtained.

The type of procedure can influence both the treatment approach and overall cost.

• Percutaneous liver biopsy:  The most commonly performed type, where a biopsy needle is inserted through the skin into the liver to obtain a tissue sample. It is suitable for most patients with normal blood clotting.
• Transjugular liver biopsy: It is performed through a vein in the neck when patients have bleeding disorders, ascites, or advanced liver disease, reducing the risk of bleeding.
• Laparoscopic liver biopsy: This is performed through small abdominal incisions using a laparoscope. It is often chosen when direct visualisation of the liver is required or when another abdominal surgery is being performed simultaneously.
• Image-guided liver biopsy: Liver biopsies may be performed under ultrasound or CT guidance to improve accuracy, particularly when targeting focal liver lesions or difficult-to-access areas.

Common Liver Biopsy Techniques

• Ultrasound-guided liver biopsy: Real-time ultrasound is used to accurately guide the biopsy needle into the liver while avoiding nearby blood vessels and surrounding organs.
• CT-guided liver biopsy: Computed tomography (CT) imaging is used to guide the biopsy needle when liver lesions are small, deep, or difficult to visualise with ultrasound.
• Core needle biopsy:  A specialised biopsy needle is used to obtain a small cylindrical sample of liver tissue for detailed microscopic examination. This is the most commonly used biopsy technique.
• Fine-Needle Aspiration (FNA): This uses a syringe to apply active suction, pulling individual cells or fragmented small pieces out via a hollow needle, used for identifying or ruling out cancerous masses.

After a liver biopsy procedure, careful attention to recovery is essential to promote proper healing and reduce the risk of complications.

• It is advised to remain under observation for the recommended period after the biopsy so that healthcare professionals can monitor for bleeding, pain, or other immediate complications.
• It is suggested to keep the biopsy site clean and dry and follow the healthcare team's instructions regarding wound care and bathing.
• If pain-relieving medications or other medicines are prescribed, they should be taken exactly as instructed. Unless approved by the doctor, avoid medications that may increase the risk of bleeding.
• It is advised to avoid alcohol consumption until the doctor confirms that it is safe, especially if the biopsy was performed to evaluate an existing liver condition.
• It is recommended to attend all scheduled follow-up appointments to discuss the biopsy results, monitor recovery, and plan any further treatment if required.

Patients needs to seek immediate medical attention if development of symptoms like severe abdominal pain, bleeding from the biopsy site, fever, chills, dizziness, shortness of breath, or increasing swelling around the biopsy area.